Judit Ovádi

6.8k total citations
150 papers, 5.5k citations indexed

About

Judit Ovádi is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Judit Ovádi has authored 150 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 48 papers in Cell Biology and 24 papers in Physiology. Recurrent topics in Judit Ovádi's work include Microtubule and mitosis dynamics (26 papers), Metabolism and Genetic Disorders (18 papers) and Cancer, Hypoxia, and Metabolism (16 papers). Judit Ovádi is often cited by papers focused on Microtubule and mitosis dynamics (26 papers), Metabolism and Genetic Disorders (18 papers) and Cancer, Hypoxia, and Metabolism (16 papers). Judit Ovádi collaborates with scholars based in Hungary, United States and Spain. Judit Ovádi's co-authors include Ferenc Orosz, Judit Oláh, Attila Lehotzky, János Kovács, Tamás Keleti, Beáta G. Vértessy, Paul A. Srere, H. Olin Spivey, Natália Tőkési and Valdur Saks and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Judit Ovádi

147 papers receiving 5.4k citations

Peers

Countries citing papers authored by Judit Ovádi

Since Specialization

Citations

This map shows the geographic impact of Judit Ovádi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Ovádi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Ovádi more than expected).

Fields of papers citing papers by Judit Ovádi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Ovádi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Ovádi. The network helps show where Judit Ovádi may publish in the future.

Co-authorship network of co-authors of Judit Ovádi

This figure shows the co-authorship network connecting the top 25 collaborators of Judit Ovádi. A scholar is included among the top collaborators of Judit Ovádi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judit Ovádi. Judit Ovádi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perspective Strategies for Interventions in Parkinsonism: Remedying the Neglected Role of TPPP 2024 ·Cells ·Judit Oláh, Victor Norris, Attila Lehotzky, Judit Ovádi	0
2	Modulatory Role of TPPP3 in Microtubule Organization and Its Impact on Alpha-Synuclein Pathology 2022 ·Cells ·Judit Oláh, Attila Lehotzky, (unknown), Tímea Berki, Judit Ovádi	8
3	Challenges in Discovering Drugs That Target the Protein–Protein Interactions of Disordered Proteins 2022 ·International Journal of Molecular Sciences ·Judit Oláh, (unknown), Attila Lehotzky, Victor Norris, Judit Ovádi	23
4	Anti-Aggregative Effect of the Antioxidant DJ-1 on the TPPP/p25-Derived Pathological Associations of Alpha-Synuclein 2021 ·Cells ·Judit Oláh, Attila Lehotzky, (unknown), Judit Ovádi	2
5	Role of Multifunctional Cytoskeletal Filaments in Coronaviridae Infections: Therapeutic Opportunities for COVID-19 in a Nutshell 2021 ·Cells ·Victor Norris, Judit Ovádi	6
6	Microtubule-Associated Proteins with Regulatory Functions by Day and Pathological Potency at Night 2020 ·Cells ·Judit Oláh, Attila Lehotzky, (unknown), (unknown), Ferenc Orosz, Judit Ovádi	23
7	Interactions between two regulatory proteins of microtubule dynamics, HDAC6, TPPP/p25, and the hub protein, DYNLL/LC8 2019 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Judit Oláh, (unknown), (unknown), Tamás Szaniszló, (unknown), Attila Lehotzky, Tímea Berki, László Nyitray, Judit Ovádi	4
8	Challenging drug target for Parkinson's disease: Pathological complex of the chameleon TPPP/p25 and alpha-synuclein proteins 2016 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Judit Oláh, (unknown), (unknown), András Láng, András Perczel, Attila Lehotzky, Vladimir N. Uversky, Judit Ovádi	23
9	Interactions of Pathological Hallmark Proteins 2011 ·Journal of Biological Chemistry ·Judit Oláh, Orsolya Vincze, Dezső P. Virók, (unknown), Zsolt Bozsó, Natália Tőkési, István Horváth, Emma Hlavanda, János Kovács, Anna Magyar, Mária Szűcs, Ferenc Orosz, Botond Penke, Judit Ovádi	119
10	TPPP/p25 Promotes Tubulin Acetylation by Inhibiting Histone Deacetylase 6 2010 ·Journal of Biological Chemistry ·Natália Tőkési, Attila Lehotzky, István Horváth, Bálint Szabó, Judit Oláh, Pierre Lau, Judit Ovádi	88
11	Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis 2010 ·Glia ·Romana Höftberger, Stephanie Fink, Fahmy Aboul‐Enein, Gergő Botond, Judit Oláh, Tímea Berki, Judit Ovádi, Hans Lassmann, Herbert Budka, Gábor G. Kovács	64
12	Triosephosphate isomerase deficiency: New insights into an enigmatic disease 2009 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Ferenc Orosz, Judit Oláh, Judit Ovádi	114
13	Unique pharmacology of KAR-2, a potential anti-cancer agent: Absorption modelling and selective mitotic spindle targeting 2008 ·European Journal of Pharmaceutical Sciences ·Isabel González‐Álvarez, Marta González‐Álvarez, (unknown), Virginia Merino, Natália Tőkési, Judit Ovádi, Marival Bermejo	6
14	New Anti-Mitotic Drugs with Distinct Anti-Calmodulin Activity 2006 ·Mini-Reviews in Medicinal Chemistry ·Ferenc Orosz, István Horváth, Judit Ovádi	10
15	Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies 2004 ·Neurobiology of Disease ·Gábor G. Kovács, Lajos László, János Kovács, Poul Henning Jensen, (unknown), Gergő Botond, Tamás Molnár, András Perczel, Ferenc Hudecz, Gábor Mező, Anna Erdei, László Tirián, Attila Lehotzky, Ellen Gelpí, Herbert Budka, Judit Ovádi	128
16	Application of metabolic control analysis to the study of toxic effects of copper in muscle glycolysis 1999 ·FEBS Letters ·(unknown), (unknown), (unknown), Judit Ovádi, Marta Cascante	22
17	Pyruvate Kinase as a Microtubule Destabilizing Factorin Vitro 1999 ·Biochemical and Biophysical Research Communications ·Beáta G. Vértessy, (unknown), János Kovács, Péter Lőw, Attila Lehotzky, Judit Ovádi	26
18	The interaction of a new anti‐tumour drug, KAR‐2 with calmodulin 1997 ·British Journal of Pharmacology ·Ferenc Orosz, Beáta G. Vértessy, C. Salerno, C Crifò, (unknown), Judit Ovádi	18
19	Interaction of a new bis‐indol derivative, KAR‐2 with tubulin and its antimitotic activity 1997 ·British Journal of Pharmacology ·Ferenc Orosz, János Kovács, Péter Lőw, Beáta G. Vértessy, (unknown), (unknown), (unknown), Judit Ovádi	20
20	Kinetic and physico-chemical analysis of enzyme complexes and their possible role in the control of metabolism 1989 ·Progress in Biophysics and Molecular Biology ·Tamás Keleti, Judit Ovádi, József Batke	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact